Virtual Medicinal Product (VMP)
-
Terazosin 1mg tablets
Name Details
Current Name
Terazosin 1mg tablets
|
Start Date
18-02-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Invalid to prescribe in NHS primary care
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Combination Product
- Component only product
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G04CA03
BNF |
Previous BNF
02050400
|
Start Date
01-06-2005
|
End Date
03-04-2022
|
Previous BNF
07040100
|
Start Date
10-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
3909211000001103 |
18-02-2003 |
|
VMP Ingredients
Name
Terazosin hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Terazosin
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Terazosin
-
VMP
(Current) Terazosin 1mg tablets
Virtual Medicinal Product Pack (VMPP) Information